NuCana (NCNA) Capital Expenditures (2017 - 2024)
NuCana's (NCNA) quarterly Capital Expenditures came in at -$1283.5 in Q4 2024, down 112.93% year-on-year from $9929.2 in Q1 2024, and down 112.93% quarter-over-quarter from $9929.2 in Q4 2023.
NuCana (NCNA) Capital Expenditures (2017 - 2024) Analysis & Trends
NuCana has disclosed Capital Expenditures across 7 years of filings, most recently posting -$1283.5 for Q4 2024.
- Capital Expenditures for Q4 2024 came in at -$1283.5, down 112.93% year-over-year; the trailing twelve-month figure through Dec 2024 was $9912.4 (down 93.26% YoY), and the FY2024 annual result was -$5113.1, down 202.77% from the prior year.
- Capital Expenditures came in at -$1283.5 for Q4 2024 at NuCana, down from $9929.2 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $938840.7 in Q4 2020 to a low of -$433608.9 in Q3 2020.
- The 4-year median for Capital Expenditures is -$4966.8 (2020), against an average of $52880.3.
- Peak annual rise in Capital Expenditures reached 873.6% in 2020, while the deepest fall reached 4294.97% in 2020.
- NuCana's Capital Expenditures stood at $938840.7 in 2020, then sank by 84.64% to $144237.1 in 2021, then tumbled by 93.12% to $9929.2 in 2023, then tumbled by 112.93% to -$1283.5 in 2024.
- The last three Capital Expenditures figures came in at -$1283.5 (Q4 2024), $9929.2 (Q4 2023), and $1266.7 (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -63,220.27 |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,283.50 |
| Dec 31, 2024 | -1,283.50 |
| Dec 31, 2023 | 9,929.22 |
| Dec 31, 2023 | 9,929.22 |
| Sep 30, 2023 | 1,266.68 |
| Sep 30, 2023 | 1,266.68 |
| Dec 31, 2021 | 144,237.13 |
| Dec 31, 2021 | 144,237.13 |
| Sep 30, 2021 | -8,271.50 |
| Sep 30, 2021 | -8,271.50 |
| Jun 30, 2021 | -46,125.03 |
| Jun 30, 2021 | -46,125.03 |
| Mar 31, 2021 | -5,515.68 |
| Mar 31, 2021 | -5,515.68 |
| Dec 31, 2020 | 938,840.66 |
| Dec 31, 2020 | 938,840.66 |
| Sep 30, 2020 | -433,608.93 |
| Sep 30, 2020 | -433,608.93 |
| Jun 30, 2020 | -4,966.78 |
| Jun 30, 2020 | -4,966.78 |